These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 23392426

  • 1. Outcomes of patients with elevated α-fetoprotein level and initial negative findings at MR imaging.
    Kim BS, Hayashi PH, Kim SH, Angthong W, Srirattanapong S, Woosley JT, Semelka RC.
    Radiology; 2013 Jul; 268(1):109-19. PubMed ID: 23392426
    [Abstract] [Full Text] [Related]

  • 2. Hepatocellular carcinoma with indeterminate or false-negative findings at initial MR imaging: effect on eligibility for curative treatment initial observations.
    Choi D, Mitchell DG, Verma SK, Bergin D, Navarro VJ, Malliah AB, McGowan C, Hann HW, Herrine SK.
    Radiology; 2007 Sep; 244(3):776-83. PubMed ID: 17690322
    [Abstract] [Full Text] [Related]

  • 3. Analysis of gadobenate dimeglumine-enhanced MR findings for characterizing small (1-2-cm) hepatic nodules in patients at high risk for hepatocellular carcinoma.
    Kim TK, Lee KH, Jang HJ, Haider MA, Jacks LM, Menezes RJ, Park SH, Yazdi L, Sherman M, Khalili K.
    Radiology; 2011 Jun; 259(3):730-8. PubMed ID: 21364083
    [Abstract] [Full Text] [Related]

  • 4. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.
    Yoo HJ, Lee JM, Lee JY, Kim SH, Kim SJ, Han JK, Choi BI.
    Invest Radiol; 2009 Dec; 44(12):800-7. PubMed ID: 19838119
    [Abstract] [Full Text] [Related]

  • 5. Hepatocellular carcinoma lesion characterization: single-institution clinical performance review of multiphase gadolinium-enhanced MR imaging--comparison to prior same-center results after MR systems improvements.
    Becker-Weidman DJ, Kalb B, Sharma P, Kitajima HD, Lurie CR, Chen Z, Spivey JR, Knechtle SJ, Hanish SI, Adsay NV, Farris AB, Martin DR.
    Radiology; 2011 Dec; 261(3):824-33. PubMed ID: 21969663
    [Abstract] [Full Text] [Related]

  • 6. Hepatocellular carcinoma in liver transplantation candidates: detection with gadobenate dimeglumine-enhanced MRI.
    Choi SH, Lee JM, Yu NC, Suh KS, Jang JJ, Kim SH, Choi BI.
    AJR Am J Roentgenol; 2008 Aug; 191(2):529-36. PubMed ID: 18647927
    [Abstract] [Full Text] [Related]

  • 7. Small (≤1-cm) hepatocellular carcinoma: diagnostic performance and imaging features at gadoxetic acid-enhanced MR imaging.
    Yu MH, Kim JH, Yoon JH, Kim HC, Chung JW, Han JK, Choi BI.
    Radiology; 2014 Jun; 271(3):748-60. PubMed ID: 24588677
    [Abstract] [Full Text] [Related]

  • 8. Hepatocellular carcinoma with a pseudocapsule on gadolinium-enhanced MR images: correlation with histopathologic findings.
    Ishigami K, Yoshimitsu K, Nishihara Y, Irie H, Asayama Y, Tajima T, Nishie A, Hirakawa M, Ushijima Y, Okamoto D, Taketomi A, Honda H.
    Radiology; 2009 Feb; 250(2):435-43. PubMed ID: 19095782
    [Abstract] [Full Text] [Related]

  • 9. Hepatocellular carcinoma in the cirrhotic liver: gadolinium-enhanced 3D T1-weighted MR imaging as a stand-alone sequence for diagnosis.
    Hecht EM, Holland AE, Israel GM, Hahn WY, Kim DC, West AB, Babb JS, Taouli B, Lee VS, Krinsky GA.
    Radiology; 2006 May; 239(2):438-47. PubMed ID: 16641353
    [Abstract] [Full Text] [Related]

  • 10. Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma.
    Ahn SS, Kim MJ, Lim JS, Hong HS, Chung YE, Choi JY.
    Radiology; 2010 May; 255(2):459-66. PubMed ID: 20413759
    [Abstract] [Full Text] [Related]

  • 11. Hepatocellular carcinoma of diffuse type: MR imaging findings and clinical manifestations.
    Kanematsu M, Semelka RC, Leonardou P, Mastropasqua M, Lee JK.
    J Magn Reson Imaging; 2003 Aug; 18(2):189-95. PubMed ID: 12884331
    [Abstract] [Full Text] [Related]

  • 12. Hepatocellular carcinoma in patients with cirrhosis: qualitative comparison of gadobenate dimeglumine-enhanced MR imaging and multiphasic 64-section CT.
    Marin D, Di Martino M, Guerrisi A, De Filippis G, Rossi M, Ginanni Corradini S, Masciangelo R, Catalano C, Passariello R.
    Radiology; 2009 Apr; 251(1):85-95. PubMed ID: 19332848
    [Abstract] [Full Text] [Related]

  • 13. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
    Sun HY, Lee JM, Shin CI, Lee DH, Moon SK, Kim KW, Han JK, Choi BI.
    Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
    [Abstract] [Full Text] [Related]

  • 14. Hepatocellular carcinoma: imaging patterns on gadoxetic acid-enhanced MR Images and their value as an imaging biomarker.
    Choi JW, Lee JM, Kim SJ, Yoon JH, Baek JH, Han JK, Choi BI.
    Radiology; 2013 Jun; 267(3):776-86. PubMed ID: 23401584
    [Abstract] [Full Text] [Related]

  • 15. Gadoxetate disodium-enhanced MR imaging: differentiation between early-enhancing non-tumorous lesions and hypervascular hepatocellular carcinomas.
    Goshima S, Kanematsu M, Watanabe H, Kondo H, Mizuno N, Kawada H, Shiratori Y, Onozuka M, Moriyama N, Bae KT.
    Eur J Radiol; 2011 Aug; 79(2):e108-12. PubMed ID: 21592707
    [Abstract] [Full Text] [Related]

  • 16. Selective prognostic impact of serum alpha-fetoprotein level in patients with hepatocellular carcinoma: analysis of 543 patients in a single center.
    Huo TI, Huang YH, Lui WY, Wu JC, Lee PC, Chang FY, Lee SD.
    Oncol Rep; 2004 Feb; 11(2):543-50. PubMed ID: 14719097
    [Abstract] [Full Text] [Related]

  • 17. Unresectable hepatocellular carcinoma: MR imaging after intraarterial therapy. Part II. Response stratification using volumetric functional criteria after intraarterial therapy.
    Bonekamp S, Halappa VG, Geschwind JF, Li Z, Corona-Villalobos CP, Reyes D, Bhagat N, Cosgrove DP, Pawlik TM, Mezey E, Eng J, Kamel IR.
    Radiology; 2013 Aug; 268(2):431-9. PubMed ID: 23616632
    [Abstract] [Full Text] [Related]

  • 18. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group.
    Ishii M, Gama H, Chida N, Ueno Y, Shinzawa H, Takagi T, Toyota T, Takahashi T, Kasukawa R.
    Am J Gastroenterol; 2000 Apr; 95(4):1036-40. PubMed ID: 10763956
    [Abstract] [Full Text] [Related]

  • 19. Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium.
    Gupta RT, Marin D, Boll DT, Husarik DB, Davis DE, Feuerlein S, Merkle EM.
    Eur J Radiol; 2012 Oct; 81(10):2457-62. PubMed ID: 22138122
    [Abstract] [Full Text] [Related]

  • 20. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH, Kim SH, Park MJ, Park CK, Rhim H.
    AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.